Quarterly report pursuant to Section 13 or 15(d)

Capital Stock Transactions

v3.2.0.727
Capital Stock Transactions
3 Months Ended
Jun. 30, 2015
Equity [Abstract]  
Capital Stock Transactions
Capital Stock Transactions
Preferred Stock
There are 2,000,000 shares of Series A Convertible Preferred Stock (“Series A”) authorized and 100,000 shares, issued and outstanding. The Series A has a par value of $0.0001 per share. The Series A holders are entitled to: (1) vote on an equal per share basis as common stock, (2) dividends paid to the common stock holders on an as if-converted basis and (3) a liquidation preference equal to the greater of $10 per share of Series A (subject to adjustment) or such amount that would have been paid to the common stock holders on an as if-converted basis.
Common Stock and Warrants
In April 2015, the Company issued 452,974 unregistered shares of common stock of the Company to a director for the cashless exercise of 666,667 warrants granted in June 2010. See additional disclosure regarding the issuance of unregistered shares at "PART II - OTHER INFORMATION", section "Item 2. Unregistered Sales of Equity Securities and Use of Proceeds".
In May 2015, the Company issued 3,333 shares of common stock of the Company for the exercise of options granted to an employee in October 2013.
In June 2015, the Company issued 333 shares of common stock of the Company for the exercise of options granted to an employee in October 2013.
Restricted Stock Agreements
From time to time, the Company enters into restricted stock agreements (“RSAs”) with certain employees and consultants. The RSAs have performance conditions, market conditions, time conditions or a combination. In some cases, once the stock vests, the individual is restricted from selling the shares of stock for a certain defined period from three months to two years depending on the terms of the RSA. As reported in our Current Reports on Form 8-K filed with the SEC on February 12, 2014 and June 25, 2014 respectively, the Company adopted a Board Member Equity Ownership Policy that supersedes any post-vesting lock-up in RSAs that are applicable to people covered by the policy which includes the Company’s board of directors and Chief Executive Officer.
Performance and Market Condition RSAs
On December 28, 2011, the Company issued 3,170,000 restricted shares with vesting criteria based on both performance and market conditions. On December 28, 2011, one third of the restricted shares vested. On July 3, 2013, the second one third of the restricted shares vested. During the year ended March 31, 2015, the Company vested 594,372 shares and cancelled 8,131 shares of the final one third of the 3,170,000 restricted shares, leaving 454,164 shares unvested. During the three month period ended June 30, 2015, the Company canceled the remaining 454,164 shares. The shares were cancelled as the vesting criteria based on both performance and market conditions were not met.
Time Condition RSAs
On various dates during the years ended March 31, 2015 and March 31, 2014, the Company issued 267,195 and 254,020 restricted shares, respectively, with vesting criteria based on time conditions. The Company has issued no additional restricted shares during the three month period ended June 30, 2015. During the three month period ended June 30, 2015 and 2014, the Company expensed $327 and $176 related to time condition RSAs, respectively. As of June 30, 2015, 93,980 remain unvested.
The following is a summary of restricted stock awards and activities for all vesting conditions for the three months ended June 30, 2015:
 
 
Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested restricted stock outstanding as of March 31, 2015
 
642,343

 
$
3.04

Granted
 

 

Vested
 
(94,199
)
 
3.85

Cancelled
 
(454,164
)
 
3.05

Unvested restricted stock outstanding as of June 30, 2015
 
93,980

 
$
3.86


All restricted shares, vested and unvested, cancelable and not cancelled, have been included in the outstanding shares as of June 30, 2015.
At June 30, 2015, there was $363 of unrecognized stock-based compensation expense, net of estimated forfeitures, related to non-vested restricted stock awards expected to be recognized over a weighted-average period of approximately 0.62 years.